Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bryan Wahl currently holds 63,959 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bryan Wahl has been a net seller of TARS stock. They have purchased $0 and sold $1.2M worth of shares.
Bryan Wahl's most recent insider trade was on Mar 19, 2026, when they sold 4,231 shares at $67.00 per share.
Bryan Wahl serves as Executive at Tarsus Pharmaceuticals, Inc. (TARS). They have executed 22 insider transactions totaling $1.2M over their tenure at the company.
Bryan Wahl holds the position of Executive at Tarsus Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Bryan Wahl has shown a selling trading pattern, with $0 in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bryan Wahl was on Mar 17, 2026, when they sold $283.5K worth of TARS shares. This transaction involved 4,084 shares at $69.42 per share.
Bryan Wahl currently owns 63,959 shares of Tarsus Pharmaceuticals, Inc. (TARS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bryan Wahl's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bryan Wahl has 22 Form 4 filings on record as an insider at Tarsus Pharmaceuticals, Inc..
Set alerts for Bryan Wahl and 40,000+ other insiders.